Cynthia Veenstra

Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer

Elin Karlsson, Cynthia Veenstra, Shad Emin et al. · Breast Cancer Research and Treatment · 2015 · 36 citations · Full text

Tumor Biology, Protein Tyrosine Phosphatase, Breast Oncology +9

The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype

Cynthia Veenstra, Elin Karlsson, Sanam Mirwani Mirwani et al. · Journal of Cancer Research and Clinical Oncology · 2019 · 22 citations · Full text

PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer

Elin Karlsson, Cynthia Veenstra, Jon Gårsjö et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 17 citations · Full text

Met and its ligand HGF are associated with clinical outcome in breast cancer

Cynthia Veenstra, Gizeh Pérez‐Tenorio, Anna Stelling et al. · Oncotarget · 2016 · 15 citations · Full text

ERBB2 and PTPN2 gene copy numbers as prognostic factors in HER2‑positive metastatic breast cancer treated with trastuzumab

Sander Elleg�rd, Cynthia Veenstra, Gizeh P�rez‐Tenorio et al. · Oncology Letters · 2019 · 10 citations · Full text